FASMAC provides food analysis and biotech products and services, including DNA/RNA synthesis, DNA sequencing, food testing, and genetic analysis reagents.
The first version of the platform, which the company submitted for Emergency Use Authorization to the US FDA last week, analyzes RNA extracted from a swab.
The company also said that it has acquired Beijing-based food safety testing firm Meizheng Group. The deal is expected to expand PerkinElmer's food safety capabilities.
UgenTec's FastFinder software platform uses artificial intelligence to enable analysis and interpretation of qPCR data, workflow automation, and genotyping.
Integrated DNA Technologies said it will act as the primary supplier of next-generation sequencing oligo products for Clear Lab's NGS-based Clear Safety platform.
The agriculture company said it will use the technology it has licensed for new applications in crop editing and for research to bring new foods to market.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
